The Road Ahead

INCREASE CAPACITIES

  • Tablet manufacturing capacity from 1.5 Billion Tablets p.a. to 3.0 Billion Tablets p.a.
  • Liquid orals manufacturing capacity from 22,000 litres per day to 32,000 litres per day

REGULATORY APPROVALS

  • WHO Prequalification for select products
  • EU GMP / MHRA (U.K.) / MCC (South Africa) / USFDA
  • Specific NGO’s / Global Institutions

GLOBAL PRESENCE

  • Grow our Global Presence in a robust but aggressive manner


NEW PRODUCTION FACILITY

  • Effervescent Solid Oral Dosage

RESEARCH & DEVELOPMENT

  • Approval from Department of Scientific and Industrial Research (DSIR) India and compliance with DSIR on a continual basis
  • Develop high volume and / or high value products for regulated markets
  • Upgrade current products for regulated markets
  • Develop products Coming off patent (2016 – 2017)

CUSTOMER SERVICE

  • Ensure maximum growth comes from current (existing & in progress) customer base by serving them efficiently and appropriately and also by adding new products routinely.
Copyrights ©2014: S Kant HEALTHCARE Ltd.